It has come to light that about 1 in 3 COVID-19 patients are diagnosed with a neuropsychiatric condition within six months of their coronavirus diagnosis, with 1 in 8 patients being newly diagnosed with neuropsychiatric conditions.

With over a year of experiencing the COVID-19 pandemic, we have the benefit of learning from new information, studying the ever-growing amount of historic COVID-19 data, and learning from our prior understanding of the way this illness affects patients.